@article{ref1,
title="Incidence of intermediate syndrome in organophosphorous poisoning",
journal="Journal of the Association of Physicians of India",
year="1995",
author="Samuel, J. and Thomas, K. and Jeyaseelan, L. and Peter, J. V. and Cherian, A. M.",
volume="43",
number="5",
pages="321-323",
abstract="Seventy two patients admitted to the Intensive Care Unit following ingestion of organophosphorus compounds were studied prospectively with two different doses of pralidoxime (PAM). One group received 1 gm immediately after admission and no further PAM and the other group received infusion of PAM, 1 gm 8 hourly for four days (total 12 gms). The incidence of type II paralysis or intermediate syndrome was 47%. We observed a higher incidence in the 4 days of infusion of PAM group (61%) (20 patients) as compared to the single Bolus dose group (39%) (13 patients). Relative risk 1.48 (confidence interval = 0.9-2.4).<p /><p>Language: en</p>",
language="en",
issn="0004-5772",
doi="",
url="http://dx.doi.org/"
}